Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000125

SVP & Chief Accounting Officer sold 357 shares at $483.36 ($172,560)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ambrose Kristen · SVP & Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-26 Sale : show line 1 in the form 10b5-1 −357 $483.36 $172,560 6,624 D
Open-market sales · 357 sh · avg $483.36 · $172,560
Loading xslF345X05/wk-form4_1772485797.xml…